Sign Up to like & get
recommendations!
0
Published in 2019 at "BMC Medical Genomics"
DOI: 10.1186/s12920-019-0552-1
Abstract: BackgroundDifferent pathogenic germline mutations in the RET oncogene are identified in MEN 2, a hereditary syndrome characterized by medullary thyroid carcinoma (MTC) and other endocrine tumors. Although genetic predisposition is recognized, not all RET mutation…
read more here.
Keywords:
medullary thyroid;
thyroid;
mtc;
ret gene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Iranian Journal of Public Health"
DOI: 10.18502/ijph.v51i5.9424
Abstract: Background: Medullary Thyroid Cancer (MTC) is a very aggressive type of thyroid carcinoma. Mutation in RET proto-oncogene is demonstrated in MTC development. We aimed to knock-out of RET-oncogene using CRISPR/Cas9 genome editing method in MTC…
read more here.
Keywords:
cell lines;
crispr cas9;
gene;
ret gene ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14215298
Abstract: Simple Summary Rearranged during transfection (RET) is a transmembrane receptor tyrosine kinase that shows targetable mutations and gene fusions in a few types of cancers. Multiple kinase inhibitors, which target RET kinase, show little efficiency…
read more here.
Keywords:
ret specific;
specific inhibitors;
kinase;
ret ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072163
Abstract: Simple Summary In this study, we employed a cell-based assay with a luciferase gene controlled by the RET promoter to identify small molecules that inhibit the transcription of the RET gene. The RET gene plays…
read more here.
Keywords:
cell;
thyroid carcinoma;
medullary thyroid;
ret gene ... See more keywords